Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Jewish General Hospital - Montreal
Montreal, Quebec, Canada
- Mcgill University Health Centre-Cedars Cancer Centre
Montreal, Quebec, Canada
- Chu de Quebec - Hopital de Saint-Sacrement
Québec, Quebec, Canada
- Breast Cancer Care Specialist
Fountain Valley, California, United States
- Orange Coast Blood and Cancer Care
Fountain Valley, California, United States
- Saddleback Memorial Medical Center
Laguna Hills, California, United States
- Coast Hematology-Oncology Associates Medical Group
Long Beach, California, United States
- Long Beach Memorial Medical Center
Long Beach, California, United States
- Oncology Hematology Consultants
Long Beach, California, United States
- Cancer Care Specialists of Central Illinois
Decatur, Illinois, United States
- Avera Cancer Institute-Sioux Falls
Sioux Falls, South Dakota, United States
- Lester and Sue Smith Breast Center
Houston, Texas, United States
- West Virginia University
Morgantown, West Virginia, United States
- Froedtert Hospital
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Oct 2018
- Primary completion
- 30 Nov 2020
- Completion
- 30 Jan 2021
- Last update posted
- 20 Apr 2022
- Registered enrollment
- 24
- Registry id
- NCT03628066
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.